SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.66 Cr | ₹2.29 Cr | ₹1.70 Cr | ₹1.44 Cr | ₹0.79 Cr |
What is the latest Long Term Provisions ratio of SAKAR HEALTHCARE ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.66 Cr |
| Mar2024 | ₹2.29 Cr |
| Mar2023 | ₹1.70 Cr |
| Mar2022 | ₹1.44 Cr |
| Mar2021 | ₹0.79 Cr |
How is Long Term Provisions of SAKAR HEALTHCARE Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.66 Cr | 16.26 | |
| Mar2024 | ₹2.29 Cr | 34.75 | |
| Mar2023 | ₹1.70 Cr | 18.08 | |
| Mar2022 | ₹1.44 Cr | 81.34 | |
| Mar2021 | ₹0.79 Cr | - | |
Compare Long Term Provisions of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,995.3 Cr | -0.6% | 12.9% | 160.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -0.6% |
12.9% |
160.3% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses